[HTML][HTML] Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel

…, D Rivera-Salinas, YG Hernández-Ruíz… - PLoS …, 2022 - journals.plos.org
Background Vaccination is our main strategy to control SARS-CoV-2 infection. Given the
decrease in quantitative SARS-CoV-2 spike 1–2 IgG antibody titers three months after the …

[HTML][HTML] Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries

…, D Rivera-Salinas, YG Hernández-Ruíz… - Frontiers in …, 2022 - frontiersin.org
Background Scarce information exists in relation to the comparison of seroconversion and
adverse events following immunization (AEFI) with different SARS-CoV-2 vaccines. Our aim …

[HTML][HTML] Analysis of immunization, adverse events, and efficacy of a fourth dose of BNT162b2 vaccine in health workers in Mexico, a pilot study

…, D Rivera-Salinas, YG Hernández-Ruíz… - Vaccines, 2022 - mdpi.com
There is scarce information on seroconversion and adverse events after immunization (AEFI)
with the fourth dose of BNT162b2. Our aim was to correlate the magnitude of the antibody …

[HTML][HTML] Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico

…, A Rivera-Cavazos, YG Hernández-Ruíz… - Vaccines, 2023 - mdpi.com
Comparisons among the different vaccines against SARS-CoV-2 are important to understand
which type of vaccine provides more protection. This study aimed to evaluate the real-life …

[HTML][HTML] Risk factors for intubation and mortality in patients treated with high flow nasal cannula due to COVID-19 infection. Survival Analysis Study in a Northern …

…, A Loose-Esparza, YG Hernández-Ruíz… - Plos one, 2024 - journals.plos.org
Background COVID-19-related acute hypoxic respiratory failure patients often use high-flow
nasal cannula (HFNO) oxygen therapy. COVID-19 HFNO intubation and mortality risk factors …

[HTML][HTML] Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers

…, D Rivera-Salinas, YG Hernández-Ruíz… - Vaccines, 2022 - mdpi.com
The efficacy of one dose Ad5-nCoV has been concerning. This study aimed to evaluate the
effect of a single dose BNT162b2 in individuals after a completed Ad5-nCoV vaccination …

[HTML][HTML] Clinical characteristics of pediatric patients with confirmed SARS-CoV-2 infection who followed rigorous measures during two years of the COVID-19 …

AC Ramírez-Cázares, YG Hernández-Ruíz… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background COVID-19 infections have been described as asymptomatic or mild, with a low
incidence of severe cases in children and adolescents who followed the basic hygiene …

Effect of the third dose of BNT162b2 vaccine in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare workers

…, D Rivera-Salinas, YG Hernández-Ruíz… - MedRxiv, 2021 - medrxiv.org
Background Vaccination is our main strategy to control SARS-CoV-2 infection. Given a decrease
in the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers three months following the …

Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers.(preprint)

…, A Gonzalez-Cantu, YG Hernandez-Ruiz… - 2021 - pesquisa.bvsalud.org
Methods: Prospective observational study included a subgroup analysis of patients who
received the Ad5-nCoV immunization during the first trimester of 2021 in a Northern city of …

Effect of the third dose of BNT162b2 vaccine in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare workers (preprint)

…, D Rivera-Salinas, YG Hernandez-Ruiz… - 2021 - pesquisa.bvsalud.org
Background: Vaccination is our main strategy to control SARS-CoV-2 infection. Given a
decrease in the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers three months following …